Usefulness of troponin-1, lactate and c-reactive protein as a prognostic markers in critically ill, non cardiac patients Source: Eur Respir J 2005; 26: Suppl. 49, 436s Year: 2005
The usefulness of cardiac troponin 1 as a prognostic marker in non cardiac critically ill patients Source: Eur Respir J 2005; 26: Suppl. 49, 522s Year: 2005
C-reactive protein/albumin ratio as a prognostic biomarker in critically ill septic patients: a prospective study Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine Year: 2020
Elevated serum high-sensitivity cardiac troponin I is related to mortality in COPD Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018
Procalcitonin and C-reactive protein levels correlate worse with organ failure than NT-proBNP levels in septic patients Source: Eur Respir J 2006; 28: Suppl. 50, 61s Year: 2006
Usefulness of lactate dehydrogenase and serum C-reactive protein in the follow-up of patients with lung transplantation Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020
Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011
Admission c-reactive protein and apache II score poorly predict loss of muscle mass in critically ill patients Source: Annual Congress 2009 - Airway management, mechanical ventilation and muscle weakness Year: 2009
Procalcitonin (PCT) and C-reactive protein (CRP) as markers of the differential diagnosis of severe community acquired pneumonia (sCAP) Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013
Usefulness of inflammatory markers: procalcitonin, neopterin, C-reactive protein and MR-proANP in the follow-up of patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008
eNAMPT as a novel diagnostic and prognostic biomarker in critically ill septic patients Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers Year: 2018
Clinical usefulness and prognostic value of elevated cardiac troponin I levels in acute pulmonary embolism Source: Eur Respir J 2004; 24: Suppl. 48, 277s Year: 2004
LATE-BREAKING ABSTRACT: The evolution of procalcitonin as a prognostic factor in critically ill patients with sepsis Source: International Congress 2015 – Acute critical care: novelties in critical care Year: 2015
Usefulness of C-reactive protein and procalcitonin in predicting mortality in community-acquired pneumonia Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008
The predictive prognostic role of elevated blood d-dimer and blood lactate in severe sepsis patients Source: Annual Congress 2009 - Acute lung injury and biomarkers Year: 2009
Levels of procalcitonin, neopterin, C-reactive protein and pro-atrial natriuretic peptide in patients with community-acquired pneumonia and its kinetic according to the severity and the development of complications Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010
Diagnostic and prognostic value of C-reactive protein in community-acquired pneumonia hospitalized patients Source: Eur Respir J 2004; 24: Suppl. 48, 188s Year: 2004
Prognostic value of echocardiography, BNP and cardiac troponin I (cTnI) in normotensive patients with pulmonary embolism Source: Eur Respir J 2005; 26: Suppl. 49, 271s Year: 2005
C-reactive protein (CRP) as a risk marker in COPD patients with ischaemic heart disease Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008
Utility of procalcitonin, neopterin, C-reactive protein and MR-proANP measurement in the management of exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008